Brief: DRI Healthcare Trust Announces Acquisition Of Royalty Interest In Worldwide Sales Of Tzield

DRI Healthcare Trust

08/03/2023 22:34

March 8 (Reuters) - Dri Healthcare Trust  DHT_u.TO :
    * DRI HEALTHCARE TRUST ANNOUNCES ACQUISITION OF A ROYALTY
INTEREST
IN THE WORLDWIDE SALES OF TZIELD™ (TEPLIZUMAB-MZWV) AND UPDATES
LONG-TERM CASH RECEIPTS OUTLOOK
    * DRI HEALTHCARE TRUST - UNIT OF DRI AGREED TO BUY
MACROGENICS'
ROYALTY INTEREST IN WORLDWIDE SALES OF TZIELD FOR UP-FRONT
PURCHASE PRICE US$100 MILLION
    * DRI HEALTHCARE TRUST - DRI EXPECTS TO FUND TRANSACTION
THROUGH
CASH RAISED IN RECENTLY ANNOUNCED US$95 MILLION PRIVATE
PLACEMENT OF PREFERRED SECURITIES
    * DRI HEALTHCARE TRUST - TRANSACTION ENTITLES DRI TO A
SINGLE
DIGIT ROYALTY ON PROVENTION'S WORLDWIDE NET SALES OF TZIELD
    * DRI HEALTHCARE TRUST - DRI WILL BE ENTITLED TO RECEIVE
QUARTERLY
ROYALTY PAYMENTS ON A ONE-QUARTER LAG BASED ON TZIELD SALES
BEGINNING JANUARY 1, 2023

Source text for Eikon:  ID:nCNWtXWfYa 
Further company coverage:  DHT_u.TO 

 ((Reuters.Briefs@thomsonreuters.com;))